Adding further complexity, secretion of AnxA1 from TNBC cells might induce autocrine signalling via FPR1 to further increase breast cancer cell aggressiveness and survival and could be blocked with cyclosporin A, a FPR1 inhibitor [96]. Here, FPR1 is linked to breast cancer.